Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 USD | -3.19% | -1.52% | -39.11% |
May. 15 | BMO Capital Adjusts Price Target on Arcadium Lithium to $5.50 From $6, Maintains Market Perform Rating | MT |
May. 10 | Arcadium Lithium Applies to Cease to be a Reporting Issuer in Canada | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company is in a robust financial situation considering its net cash and margin position.
- The company appears to be poorly valued given its net asset value.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With an enterprise value anticipated at 4.45 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-39.11% | 5.05B | B+ | ||
+17.53% | 66.74B | A- | ||
+3.73% | 49.42B | A- | ||
+21.67% | 42.17B | B+ | ||
+21.48% | 26.37B | A- | ||
+10.57% | 19.17B | C+ | ||
-2.43% | 16.73B | B+ | ||
+5.88% | 15.99B | B+ | ||
-14.90% | 14.86B | C+ | ||
-27.16% | 14.85B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALTM Stock
- Ratings Arcadium Lithium plc